ProVise Management Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,134
Closed -$215K 301
2023
Q4
$215K Buy
+2,134
New +$212K 0.02% 317
2023
Q1
Sell
-4,306
Closed -$331K 345
2022
Q4
$331K Buy
+4,306
New +$327K 0.03% 246
2021
Q3
Sell
-5,128
Closed -$293K 379
2021
Q2
$293K Buy
+5,128
New +$300K 0.03% 300

Other funds holding CAH

ProVise Management Group's CAH Position: Q1 2024 in Review

ProVise Management Group sold out of Cardinal Health (CAH) in Q1 2024, closing a stake of 2,134 shares — an estimated $215K sold.

ProVise Management Group first reported a position in CAH in Q2 2021 and held it in 3 quarters. The position peaked at $331K in Q4 2022. 1,057 funds tracked by Wall St. Rank hold CAH as of Q1 2024.

  • ProVise Management Group reported no remaining Cardinal Health position as of Q1 2024 after selling out during the quarter.
  • ProVise Management Group sold 2,134 Cardinal Health shares in Q1 2024, an estimated $215K.
  • ProVise Management Group first reported a position in Cardinal Health in Q2 2021 and held it in 3 quarters.
  • ProVise Management Group's Cardinal Health position peaked at $331K in Q4 2022.
  • 1,057 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2024.

Based on ProVise Management Group's 13F filing for Q1 2024, filed 9 May 2024.